Abstract
The purpose of this investigation was to evaluate the role of cytochrome P450 (CYP) 3A4 in human liver microsomal bupropion (BUP) hydroxylation. Across the BUP concentration range of 0.075 to 12 mM, cDNA-expressed CYP3A4 demonstrated BUP hydroxylase activity only when incubated with concentrations ≥4 mM. When assayed at 12 mM BUP, cDNA-expressed CYP3A4 catalyzed BUP hydroxylation at a 30-fold lower rate than cDNA-expressed CYP2B6 (0.2 versus 7 pmol/min/pmol of P450). Among a panel of 16 human liver microsomes (HLMs), BUP hydroxylase activity varied 80-fold when assayed at 500 μM and did not strongly correlate with testosterone 6β-hydroxylase activity when assayed at 250 μM testosterone (r2 = 0.39), nor with CYP3A4 protein expression. A selective CYP3A4 inhibitor, troleandomycin (TAO), did not significantly alter rates of BUP hydroxylation when assayed in a moderate activity HLM at 10 to 2000 μM BUP, as reflected by a similarity in the kinetic parameters of BUP hydroxylation in the absence or presence of TAO. In addition, the same range of TAO concentrations (0.025–100 μM) that inhibited testosterone 6β-hydroxylation in a concentration-dependent manner (46–81%) in pooled HLMs produced negligible inhibition (7%) of BUP hydroxylation when assayed at 500 μM BUP. These results suggest that CYP3A4 does not significantly catalyze BUP hydroxylation. Furthermore, these results complement recent data supporting selectivity of BUP hydroxylation for CYP2B6 at 500 μM BUP.
Footnotes
-
This work was supported in part by a Hollingsworth Faculty Scholarship awarded to C.M.L. by the School of Pharmacy, University of North Carolina at Chapel Hill and by a Junior Faculty Development Award awarded to E.L.L. by the University Research Council, University of North Carolina at Chapel Hill. Results from this work have been presented in poster format at the American Society for Clinical Pharmacology and Therapeutics Annual Meeting, Los Angeles, CA, March 15, 2000, and have been published in abstract form in Clin Pharmacol Ther (2000) 67:99 (abstract PI-41).
- Abbreviations used are::
- BUP
- bupropion
- HBUP
- hydroxybupropion
- AUC
- area under the plasma concentration-time curve
- CYP or P450
- cytochrome P450
- HLM
- human liver microsome
- TAO
- troleandomycin
- HPLC
- high-performance liquid chromatography
- Received December 28, 2000.
- Accepted April 23, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|